Andros Pharmaceuticals Co.,Ltd
6917.TWO
Taipei Exchange31.50
TWD
-NaN
- -
Total Valuation
Andros Pharmaceuticals Co.,Ltd carries a market capitalization of 1.38B, placing it among publicly traded companies globally.
| Market Cap | 1.38B |
| Enterprise Value | N/A |
Stock Price Statistics
Andros Pharmaceuticals Co.,Ltd's stock has gained approximately 93.25153% over the past 52 weeks. The 50-day moving average sits at 32.30, while the 200-day moving average is 24.70.
| Beta (5Y) | N/A |
| 52-Week Price Change | 93.25153% |
| 50-Day Moving Average | 32.30 |
| 200-Day Moving Average | 24.70 |
| Average Volume (20 Days) | N/A |
Stock Splits
Andros Pharmaceuticals Co.,Ltd's most recent stock split took place on July 18, 2023 with a 50:53 split ratio.
| Last Split Date | 7/18/2023 |
| Split Ratio | 50:53 |